Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Direct Flow makes ex-CoreValve CEO new chief

This article was originally published in Clinica

Executive Summary

Transcatheter aortic valve implantation (TAVI) specialist Direct Flow Medical has signalled its intent to compete with the likes of Medtronic and Edwards Lifesciences by appointing a new heavyweight CEO. Daniel Lemaitre was previously in charge at CoreValve, which was acquired by Medtronic for $800m; before that, he led strategic planning and business development for Medtronic. Mr Lemaitre replaces Bernard Lyons, who will be retiring. Direct Flow also named David Boyle as CFO – he has held the position at five healthcare companies including, most recently, drug developer Ogenx Therapeutics. Direct Flow has developed a CE-marked repositionable and retrievable valve that it claims completely eliminates aortic regurgitation, a complication seen with older products. It is currently carrying out a pivotal study in the US, SALUS, and has previously said it hopes for FDA approval in the first half of 2017.

You may also be interested in...

What are the hottest innovations from Israel?

Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.

EuroPCR: St Jude and Philips talk up rival intravascular imaging techs

St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.

EuroPCR: Medtronic's drug-coated balloon keeps rising

A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts